{"id":961587,"date":"2026-05-12T13:01:23","date_gmt":"2026-05-12T17:01:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/"},"modified":"2026-05-12T13:01:23","modified_gmt":"2026-05-12T17:01:23","slug":"the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/","title":{"rendered":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">NEW YORK<\/span>, <span class=\"legendSpanClass\">May 12, 2026<\/span> \/PRNewswire\/ &#8212;\u00a0The Gross Law Firm issues the following notice to shareholders of\u00a0<b>Atara Biotherapeutics, Inc. <\/b>(NASDAQ: ATRA).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" title=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" alt=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders who purchased shares of ATRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p class=\"prntac\">CONTACT US HERE:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4685578-10&amp;h=1424937885&amp;u=https%3A%2F%2Fsecuritiesclasslaw.com%2Fsecurities%2Fatara-biotherapeutics-inc-loss-submission-form%2F%3Fid%3D186273%26from%3D4&amp;a=https%3A%2F%2Fsecuritiesclasslaw.com%2Fsecurities%2Fatara-biotherapeutics-inc-loss-submission-form%2F%3Fid%3D186273%26from%3D4\" target=\"_blank\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/atara-biotherapeutics-inc-loss-submission-form\/?id=186273&amp;from=4<\/a>\u00a0<\/p>\n<p>\n        <b>CLASS PERIOD: <\/b>May 20, 2024 to January 9, 2026<\/p>\n<p>\n        <b>ALLEGATIONS: <\/b>The complaint <span>alleges<\/span> that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) certain manufacturing issues, as well as deficiencies inherent in the ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel&#8217;s regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical trials; (iv) all the foregoing was likely to have a significant negative impact on Atara&#8217;s business and financial condition; and (v) as a result, defendants&#8217; public statements were materially false and\/or misleading at all relevant times.<\/p>\n<p>\n        <b>DEADLINE: May 22, 2026<\/b> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/securitiesclasslaw.com\/securities\/atara-biotherapeutics-inc-loss-submission-form\/?id=186273&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/atara-biotherapeutics-inc-loss-submission-form\/?id=186273&amp;from=4<\/a><\/p>\n<p>\n        <b>NEXT STEPS FOR SHAREHOLDERS: <\/b>Once you register as a shareholder who purchased shares of ATRA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 22, 2026. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <b>WHY GROSS LAW FIRM? <\/b>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, <span>fraud<\/span>, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"mailto:dg@securitiesclasslaw.com\" rel=\"nofollow\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=NY56361&amp;sd=2026-05-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit---atra-302769282.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit&#8212;atra-302769282.html<\/a><\/p>\n<p>SOURCE The Gross Law Firm<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY56361&amp;Transmission_Id=202605120900PR_NEWS_USPR_____NY56361&amp;DateId=20260512\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, May 12, 2026 \/PRNewswire\/ &#8212;\u00a0The Gross Law Firm issues the following notice to shareholders of\u00a0Atara Biotherapeutics, Inc. (NASDAQ: ATRA). Shareholders who purchased shares of ATRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/atara-biotherapeutics-inc-loss-submission-form\/?id=186273&amp;from=4\u00a0 CLASS PERIOD: May 20, 2024 to January 9, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) certain manufacturing issues, as well as deficiencies inherent in the ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel&#8217;s regulatory prospects &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-961587","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, May 12, 2026 \/PRNewswire\/ &#8212;\u00a0The Gross Law Firm issues the following notice to shareholders of\u00a0Atara Biotherapeutics, Inc. (NASDAQ: ATRA). Shareholders who purchased shares of ATRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/atara-biotherapeutics-inc-loss-submission-form\/?id=186273&amp;from=4\u00a0 CLASS PERIOD: May 20, 2024 to January 9, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) certain manufacturing issues, as well as deficiencies inherent in the ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel&#8217;s regulatory prospects &hellip; Continue reading &quot;The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-12T17:01:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA\",\"datePublished\":\"2026-05-12T17:01:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/\"},\"wordCount\":437,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/\",\"name\":\"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"datePublished\":\"2026-05-12T17:01:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/","og_locale":"en_US","og_type":"article","og_title":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - Market Newsdesk","og_description":"PR Newswire NEW YORK, May 12, 2026 \/PRNewswire\/ &#8212;\u00a0The Gross Law Firm issues the following notice to shareholders of\u00a0Atara Biotherapeutics, Inc. (NASDAQ: ATRA). Shareholders who purchased shares of ATRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/atara-biotherapeutics-inc-loss-submission-form\/?id=186273&amp;from=4\u00a0 CLASS PERIOD: May 20, 2024 to January 9, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) certain manufacturing issues, as well as deficiencies inherent in the ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel&#8217;s regulatory prospects &hellip; Continue reading \"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-12T17:01:23+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA","datePublished":"2026-05-12T17:01:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/"},"wordCount":437,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/","name":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","datePublished":"2026-05-12T17:01:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-22-2026-in-atara-biotherapeutics-inc-lawsuit-atra\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit &#8211; ATRA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/961587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=961587"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/961587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=961587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=961587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=961587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}